IP Library Granted Patent US 10,662,261
Granted Patent B2
US 10,662,261 · App. 15/937,428 · Granted May 26, 2020

Chelator and use thereof

Inventors: Mattias Algotsson (Uppsala, SE); Lars C. Andersson (Uppsala, SE); Eggert Brekkan (Uppsala, SE); Lee Hedemyr (Uppsala, SE); Jean-Luc Maloisel (Uppsala, SE); Ronnie Palmgren (Uppsala, SE)
Assignee: GE Healthcare BioProcess R&D AB
C08B37/0039B01J20/281B01J20/289B01J20/3219B01J20/3251B01J20/3265C07C237/10C07C323/60
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,662,261
App. No.
15/937,428
Granted
May 26, 2020
Kind
B2
Abstract

The present invention relates to dimeric pentadentate chelators with exceptionally strong binding of metal ions, for detection, immobilization and purification of biomolecules. Dimeric chelators offer a cooperativity of binding of two adjacent immobilized metal ions simultaneously to a histidine-tagged biomolecule, which gives advantageous properties regarding strength of binding compared to a corresponding monomer chelator. In addition, a dimer increases the selectivity (ease of separation) against non-tagged biomolecules with low metal-ion affinity.

Claims (21)

1. A dimeric pentadentate chelator having the following general formula:

wherein Q is a solid phase, a detection label, or a biomarker,

wherein Sc is a scaffold that contains at least two functional groups that couple two pentadentate chelators (PD), wherein Sc comprises diethylenetriamine, and

wherein PD is a pentadentate chelator having the formula:

2. The dimeric pentadentate chelator of claim 1 , wherein Q is a solid phase comprising a natural or synthetic polymer.

3. The dimeric pentadentate chelator of claim 2 , wherein the solid phase is a porous chromatographic support.

4. The dimeric pentadentate chelator of claim 2 , wherein Q is made of a cross-linked carbohydrate material.

5. The dimeric pentadentate chelator of claim 4 , wherein the cross-linked carbohydrate material is agarose, agar, cellulose, dextran, chitosan, konjac, carrageenan, gellan, or alginate.

6. The dimeric pentadentate chelator of claim 4 , wherein the cross-linked carbohydrate material is agarose.

7. The dimeric pentadentate chelator of claim 2 , wherein Q is made of one or more synthetic polymers.

8. The dimeric pentadentate chelator of claim 7 , wherein the one or more synthetic polymers comprise styrene derivatives, divinylbenzene, acryl amides, acrylate esters, methacrylate esters, vinyl esters, vinyl amides, or a combination thereof.

9. The dimeric pentadentate chelator of claim 2 , wherein Q comprises magnetic particles.

10. The dimeric pentadentate chelator of claim 1 , wherein Q is a solid phase comprising a sensor surface.

11. A dimeric pentadentate chelator having the following general formula:

wherein Q is a solid phase, a detection label, or a biomarker,

wherein Sc is a scaffold that contains at least two functional groups that couple two pentadentate chelators (PD), wherein Sc comprises diethylenetriamine,

wherein PD is a pentadentate chelator having the formula:

and

wherein Sp is a spacer provided between the scaffold Sc and the group Q, wherein the spacer has the following formula Xf-SP-Yf before coupling to Q and Sc, wherein Xf and Yf are selected from —OH, —SH or —OCH 2 CH═CH 2 , —CO 2 H, —NH 2 or NH—, —N 3 , CN, OTs, OMs, Cl, Br, —CHO, —C≡CH or epoxide groups, and wherein SP is a straight or branched configuration of 2-100 atoms comprising C, N, O, S and H.

12. The dimeric pentadentate chelator of claim 11 , wherein Xf is —CO 2 H and Yf is —SH.

13. The dimeric pentadentate chelator of claim 11 , wherein the spacer is derived from mercapto hexanoic acid.

Assignments (2)
CHANGE OF NAME Recorded Oct 5, 2020
From: GE HEALTHCARE BIOPROCESS R&D AB
To: CYTIVA BIOPROCESS R&D AB
Reel/Frame 054299/0349 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 19, 2018
From: ALGOTSSON, MATTIAS; ANDERSSON, LARS C.; BREKKAN, EGGERT; HEDEMYR, LEE; MALOISEL, JEAN-LUC; PALMGREN, RONNIE
To: GE HEALTHCARE BIOPROCESS R&D AB
Reel/Frame 046126/0210 →